178 related articles for article (PubMed ID: 33378279)
1. Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study.
Al-Madfaa RO; Alalawi MA; Basudan LO; Alhejaili SF; Eljaaly K; Madani TA; Thabit AK
J Infect Dev Ctries; 2020 Dec; 14(12):1380-1386. PubMed ID: 33378279
[TBL] [Abstract][Full Text] [Related]
2. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
[TBL] [Abstract][Full Text] [Related]
3. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
[TBL] [Abstract][Full Text] [Related]
5. Update on treatment options for spinal brucellosis.
Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
[TBL] [Abstract][Full Text] [Related]
7. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and treatment outcomes of human brucellosis at a tertiary care center in Saudi Arabia.
Edathodu J; Alamri M; Alshangiti KA; Alfagyh NS; Alnaghmush AS; Albaiz F; Alothman B; Khalil H; Edathodu Z; Alrajhi AA
Ann Saudi Med; 2021; 41(2):109-114. PubMed ID: 33818142
[TBL] [Abstract][Full Text] [Related]
9. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials.
Skalsky K; Yahav D; Bishara J; Pitlik S; Leibovici L; Paul M
BMJ; 2008 Mar; 336(7646):701-4. PubMed ID: 18321957
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
[TBL] [Abstract][Full Text] [Related]
12. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Alp E; Koc RK; Durak AC; Yildiz O; Aygen B; Sumerkan B; Doganay M
BMC Infect Dis; 2006 Apr; 6():72. PubMed ID: 16606473
[TBL] [Abstract][Full Text] [Related]
14. Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature.
Memish ZA; Venkatesh S
BJU Int; 2001 Jul; 88(1):72-6. PubMed ID: 11446850
[TBL] [Abstract][Full Text] [Related]
15. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
Bayindir Y; Sonmez E; Aladag A; Buyukberber N
J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three different combination therapies in the treatment of human brucellosis.
Ersoy Y; Sonmez E; Tevfik MR; But AD
Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
[TBL] [Abstract][Full Text] [Related]
17. Early clinical response to different therapeutic regimens for human brucellosis.
Malik GM
Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.
Solís García del Pozo J; Solera J
PLoS One; 2012; 7(2):e32090. PubMed ID: 22393379
[TBL] [Abstract][Full Text] [Related]
19. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
[TBL] [Abstract][Full Text] [Related]
20. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
